The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7893045 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 22, 2011

Filed:

Aug. 05, 2008
Applicants:

Dennis Pietronigro, Clinton, NJ (US);

Annette Ervin-hayes, Watchung, NJ (US);

Jerome B. Zeldis, Princeton, NJ (US);

Inventors:

Dennis Pietronigro, Clinton, NJ (US);

Annette Ervin-Hayes, Watchung, NJ (US);

Jerome B. Zeldis, Princeton, NJ (US);

Assignee:

Celgene Corporation, Summit, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Methods for predicting a response of a patient having a lymphoma to a therapy regimen of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione using prognostic factors of a patient's disease burden, absolute lymphocyte count or time since last rituximab therapy are disclosed. Specific methods of treating a lymphoma encompass the administration of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione to a patient who has one or more of the favorable profiles, alone or in combination with immunosuppressive agents such as rituximab.


Find Patent Forward Citations

Loading…